News Releases

News and information from The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society Awards $15.6 Million to Help Advance Research from Lab to Clinic

Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (Oct. 29, 2014) -- The Leukemia & Lymphoma Society (LLS) is awarding $15.6 million in academic grants to 26 scientists who have proposed innovative laboratory research that shows promise in leading to new treatments for blood cancer patients. The funds are being awarded through LLS's Translational Re...

The Leukemia & Lymphoma Society Launches New Initiative to Halt the Progression of Myeloid Blood Cancers

Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (October 28, 2014) - The Leukemia & Lymphoma Society has initiated a program to fund research projects seeking to better understand and, ultimately, stop progression of certain types of blood cancers from early-stage malignancies to much more lethal states of disease. The types of early-stage blood cancers the...

The Leukemia & Lymphoma Society Announces Recipients of Grants Supporting New Drug Discovery

Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (Oct. 21, 2014) - For the second year, The Leukemia & Lymphoma Society (LLS) will award funding to leading scientists and researchers who show promise in developing new drug therapies through the Screen to Lead Program. The collaborative program aims to support academic laboratories pursuing research directed towar...

The Leukemia & Lymphoma Society Awards Six New Research Grants Focused on Innovative New Ideas

Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (October 20, 2014) -  Six academic investigators will receive grants from The Leukemia & Lymphoma Society (LLS) to support innovative ideas that that have the potential to take research in a new direction and fundamentally impact the future of blood cancer diagnosis and treatment. The second-year grant program...

Immunotherapy Study Funded by The Leukemia & Lymphoma Society Demonstrates Remarkable Results in Patients with Acute Lymphoblastic Leukemia

Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (October 16, 2014) - Funding from The Leukemia & Lymphoma Society (LLS) over the past 22 years helped advance a study published today in the New England Journal of Medicine showing that 90 percent of children and adults with acute lymphoblastic leukemia (ALL) achieved complete remission after receiving an investigatio...

Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative With Oregon Health & Science University

Contact: Andrea Greif, Senior Director of Communications 
The Leukemia & Lymphoma Society
914-821-8958
andrea.greif@lls.org SAN DIEGO, CALIFORNIA and TORONTO, CANADA; PORTLAND, OREGON; WHITE PLAINS, NEW YORK - September 29, 2014 - Aptose Biosciences Inc. (TSX: APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechan...

Louis J. DeGennaro, Ph.D., Named President and Chief Executive Officer of The Leukemia & Lymphoma Society

Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (September 9, 2014) - The Leukemia & Lymphoma Society (LLS) announced today that Louis J. DeGennaro, Ph.D., has been appointed as president and chief executive officer, effective immediately. "Dr. DeGennaro has tirelessly dedicated himself for almost a decade of service to the LLS mission and to the patients whom w...

The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine

Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (Aug. 28, 2014) - The Leukemia & Lymphoma Society (LLS) and OncoPep have entered a partnership to advance an experimental cancer vaccine to treat patients with smoldering multiple myeloma (SMM), an asymptomatic stage of myeloma. The partnership is through LLS's Therapy Acceleration Program® (TAP), through which LL...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: